0001019056-19-000184.txt : 20190304 0001019056-19-000184.hdr.sgml : 20190304 20190304210919 ACCESSION NUMBER: 0001019056-19-000184 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190228 FILED AS OF DATE: 20190304 DATE AS OF CHANGE: 20190304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stromatt Scott C CENTRAL INDEX KEY: 0001679975 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37746 FILM NUMBER: 19656375 MAIL ADDRESS: STREET 1: 2401 4TH AVENUE STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aptevo Therapeutics Inc. CENTRAL INDEX KEY: 0001671584 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811567056 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 206-838-0500 MAIL ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 4 1 stromatt.xml X0306 4 2019-02-28 0 0001671584 Aptevo Therapeutics Inc. APVO 0001679975 Stromatt Scott C 2401 4TH AVENUE SUITE 1050 SEATTLE WA 98121 0 1 0 0 Chief Medical Officer and SVP Common Stock 2019-03-01 4 M 0 16269 A 221006 D Common Stock 2019-03-01 4 F 0 4823 1.57 D 216183 D Stock Option (right to buy) 1.52 2019-02-28 4 A 0 67400 0 A 2029-02-28 Common Stock 67400 67400 D Restricted Stock Unit 2019-03-01 4 M 0 16269 0 D Common Stock 16269 0 D Restricted stock units (the "RSUs") convert into shares of the Issuer's common stock on a one-for-one basis. The option vests in three approximately equal annual installments beginning on February 28, 2020. The RSUs were originally issued by Emergent BioSolutions, Inc. ("Emergent") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the "Spin-off"), each RSU was adjusted and assumed by the Issuer. The RSUs vested in three equal annual installments beginning on the anniversary of the grant date. /s/ Carl A. Valenstein, attorney-in-fact 2019-03-04